| ￥1200 | |
| A03507-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to Glucagon |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Glucagon |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||
|
|||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of GLP1 expression in human fetal pancreas lysate. »
| Target Background | Glucagon: Plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes. |
| Synonyms | GCG; GLP-1(7-36); GLP-1(7-37); GLP-2; GLP1; GLP2; Glucagon; GRPP; preproglucagon; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
